Toggle Health Problems and D

Chronic Hives treated by Vitamin D - many studies

Hives treated by 28,000 IU of Vitamin D weekly – RCT Aug 2020

The effect of vitamin D add-on therapy on the improvement of quality of life and clinical symptoms of patients with chronic spontaneous urticaria
 Download the PDF from Vitamin D Life

Hives treated by 60,000 IU of Vitamin D every two weeks – RCT May 2020

Effect of vitamin D supplementation on clinical outcome and biochemical profile in South Indian population with vitamin D-deficient chronic urticarial – A randomized double-blind placebo controlled trial
Clinica Chimica Acta, Volume 504, May 2020, Pages 1-6, https://doi.org/10.1016/j.cca.2020.01.003
ArchanaMonyaLaxmishaChandrashekarb1MedhaRajappaaMalathiMunisamybJaya PrakashSahoocSandhiyaSelvarajand


  • Chronic urticaria (CU) is a debilitating inflammatory skin disease.
  • This study assessed the effect of vitamin D supplementation on outcomes in CU.
  • Decrease in UAS7 and medication usage was seen in the intervention group, compared with placebo.
  • Vitamin D supplementation led to decreased systemic inflammation, hence improving disease course and quality of life in CU.

Chronic urticaria (CU) is a debilitating inflammatory skin disease. Prior studies have shown reduced concentrations of vitamin D in CU and there are limited reports of potential beneficial role for vitamin D supplementation in the treatment of subjects with CU. We assessed the effect of vitamin D supplementation in vitamin D deficient CU patients on the clinical outcome and inflammatory markers in South Indian patients with CU.

This randomized controlled trial involved 120 vitamin-D deficient CU patients. Urticaria activity score (UAS7) and autologous plasma skin test (APST) status was assessed in all cases. CU patients were supplemented with vitamin D with a dose of 60,000 IU fortnightly for a period of 12 weeks and those in the placebo arm received matched placebo. Five milliliters of blood was drawn from all study subjects at baseline and after 12 weeks for assessing inflammatory markers.

We observed a significant reduction in UAS7 scores after 12 weeks in the vitamin D treated group in comparison to that of placebo. We also noted a significant reduction of the inflammatory cytokines in the vitamin D treated group.

Supplementation with vitamin D among patients with vitamin D deficient CU significantly decreases disease severity which is probably mediated through reduction of systemic inflammation.

Hives treatment augmented by 60,000 IU Vitamin D weekly – RCT June 2015

Hives treatment augmented by 60,000 IU Vitamin D weekly – RCT June 2015 which has the following chart

Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study.

Ann Allergy Asthma Immunol. 2014 Feb 5. pii: S1081-1206(14)00012-X. doi: 10.1016/j.anai.2014.01.010.
Rorie A 1, Goldner WAS 2, Lyden E3, Poole JA 4.

  • 1Pulmonary, Critical Care, Sleep, and Allergy Division, Department of Medicine, College of Medicine, University of Nebraska Medical Center, The Nebraska Medical Center, Omaha, Nebraska.
  • 2Diabetes, Endocrinology and Metabolism Division, Department of Medicine, College of Medicine, University of Nebraska Medical Center, The Nebraska Medical Center, Omaha, Nebraska.
  • 3Department of Biostatistics, College of Public Health; University of Nebraska Medical Center, The Nebraska Medical Center, Omaha, Nebraska.
  • 4Pulmonary, Critical Care, Sleep, and Allergy Division, Department of Medicine, College of Medicine, University of Nebraska Medical Center, The Nebraska Medical Center, Omaha, Nebraska. japoole at unmc.edu.

BACKGROUND: Observational reports have linked vitamin D with chronic urticaria, yet no randomized controlled trial has been conducted.

OBJECTIVE: To determine whether high-dose vitamin D supplementation would decrease Urticaria Symptom Severity (USS) scores and medication burden in patients with chronic urticaria.

METHODS: In a prospective, double-blinded, single-center study, 42 subjects with chronic urticaria were randomized to high (4,000 IU/d) or low (600 IU/d) vitamin D3 supplementation for 12 weeks.
All subjects were provided with a standardized triple-drug therapy (

  • cetirizine,
  • ranitidine, and
  • montelukast)

and a written action plan. Data on USS scores, medication use, blood for 25-hydroxyvitamin D, and safety measurements were collected.

RESULTS: Triple-drug therapy decreased total USS scores by 33% in the first week. There was a further significant decrease (40%) in total USS scores in the high, but not low, vitamin D3 treatment group by week 12. Compared with low treatment, the high treatment group demonstrated a trend (P = .052) toward lower total USS scores at week 12, which was driven by significant decreases in body distribution and number of days with hives. Beneficial trends for sleep quality and pruritus scores were observed with high vitamin D3. Serum 25-hydroxyvitamin D levels increased with high vitamin D3 supplementation, but there was no correlation between 25-hydroxyvitamin D levels and USS scores. There was no difference in allergy medication use between groups. No adverse events occurred.

CONCLUSION: Add-on therapy with high-dose vitamin D3 (4,000 IU/d) could be considered a safe and potentially beneficial immunomodulator in patients with chronic urticaria.

Copyright © 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

PMID: 24507460

Vitamin D will probably boost urticaria therapy - Aug 2014

Vitamin D supplementation: a potential booster for urticaria therapy.
Expert Rev Clin Immunol. 2014 Aug 26:1-3. [Epub ahead of print]
Rorie A1, Poole JA. japoole at unmc.edu

Chronic urticaria is a common skin condition whereby the etiology remains largely idiopathic and the mainstay therapy is symptomatic control with antihistamines. There have been a limited number of small studies suggesting a potential role for vitamin D in chronic urticaria, and this this editorial review will discuss the current supporting evidence. Associations for decreased serum vitamin 25 hydroxyvitamin D levels in subjects with chronic urticaria have been reported. In addition to observational reports, there has been a randomized, prospective, blinded trial demonstrating symptom improvement when high vitamin D3 supplementation was utilized as an add-on therapy for urticarial management. More research is needed to address mechanisms of action and to investigate vitamin D supplementation in larger and longer duration human trials.

PMID: 25155458
Publisher wants $89 for you to borrow the PDF for 1 day

Hives helped by daily 20,000 IU of Vitamin D2 - July 2014

Vitamin d supplements improve urticaria symptoms and quality of life in chronic spontaneous urticaria patients: a prospective case-control study.
Dermatoendocrinol. 2014 Jul 16;6:e29727. doi: 10.4161/derm.29727. eCollection 2014.
Boonpiyathad T, Pradubpongsa P, Sangasapaviriya A.
Division of Allergy and Clinical Immunology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.

Vitamin D plays an important role in the immune system; decreased serum vitamin D concentrations have been linked to dysregulated immune function. Low vitamin D status is probably associated with chronic spontaneous urticaria (CSU). We evaluated the prevalence of low vitamin D status, and the clinical response and quality of life following vitamin D supplementation, in a prospective case-control study with 60 CSU patients and 40 healthy individuals. Serum 25-hydroxy vitamin D (25(OH)D) concentrations were measured at baseline and after 6 weeks. For patients with 25(OH)D concentrations < 30 ng/ml, treatment included 20,000 IU/day of ergocalciferol (vitamin D2) and non-sedative antihistamine drugs for 6 weeks. Urticaria symptom severity and quality of life were assessed based on the Urticaria Activity Score over 7 days (UAS7) and the Dermatology Life Quality Index (DLQI). Of the 100 participants, 73% were female; the mean age was 39 ± 16 years. Vitamin D deficiency (measured as 25(OH)D < 20 ng/ml) was significantly higher in the CSU group than the control group. The median 25(OH)D concentration for the CSU group, 15 (7 - 52) ng/ml was significantly lower than for control group, 30 (25 - 46) ng/ml. Overall, 83% (50/60) of CSU patients (25(OH)D < 30 ng/ml) were treated with ergocalciferol (vitamin D2) supplementation; after 6 weeks, these patients showed significant improvements in UAS7 and DLQI scores compared with the non-vitamin D supplement group. This study revealed a significant association of lower serum 25(OH)D concentrations with CSU. Vitamin D supplements might improve symptoms and quality of life in CSU patients.

PMID: 25346784

Vitamin d deficiency 2.5 X more likely with hives - April 2015

Vitamin d deficiencyin chronic idiopathic urticaria
Iran J Allergy Asthma Immunol. 2015 Apr;14(2):222-7.
Movahedi M1, Tavakol M2, Hirbod-Mobarakeh A3, Gharagozlou M1, Aghamohammadi A4, Tavakol Z5, Momenzadeh K6, Nabavi M7, Dabbaghzade A1, Mosallanejad A8, Rezaei N9.

Chronic urticaria is the most common skin diseases, characterized by chronic cutaneous lesions which severely debilitates patients in several aspects of their everyday life. Vitamin D is known to exert several actions in the immune system and to influence function and differentiation of mast cells, central role players in the pathogenesis of chronic idiopathic urticaria. This study was performed to evaluate the relationship between vitamin D levels and susceptibility to chronic idiopathic urticaria. One hundred and fourteen patients with chronic idiopathic urticaria were recruited in this study along with one hundred and eighty seven sex-matched and age-matched healthy volunteers as the control group. For each patient, urticaria activity score was calculated and autologous serum skin test was done. Vitamin D metabolic statue was measured in serum as 25 hydroxyvitamin D using enzyme immunoassay method. Patients with chronic idiopathic urticaria significantly showed lower levels of vitamin D. Vitamin D deficiency was significantly associated with increased susceptibility to chronic idiopathic urticaria. There was a significant positive correlation between vitamin D levels and urticaria activity score. This study showed that patients with chronic idiopathic urticaria had reduced levels of vitamin D, while vitamin D deficiency could increase susceptibility to chronic idiopathic urticaria.

Clipped from results
Patients with CIU and particularly with true CIU significantly showed lower levels of 25 (OH)D in
comparison with the control group (p=0.005) (Figure 1). However, considering AICU patients separately,
there was no significant differences in vitamin D levels between them and the control group (p=0.11). Vitamin
D deficiency was significantly associated with increased susceptibility to CIU (p=0.001). Individuals
with vitamin D deficiency showed a 2.4-fold (95%CI: 1.4-4) risk of having CIU. In addition, vitamin D
deficiency significantly increased susceptibility to true CIU (p=0.001, OR=2.7, 95%CI: 1.4-5.1). However,
slight significant difference was detected between the controls and the AICU patients regarding vitamin D
deficiency (p=0.048, OR=2.04, 95%CI: 0.99-4.2)(Table 2).

PMID: 25780889
 Download the PDF from Vitamin D Life

Chronic Urticaria helped by 300,000 IU of vitamin D monthly Aug 2015

Does replacement of vitamin D reduce the symptom scores and improve quality of life in patients with chronic urticaria?
J Dermatolog Treat. 2015 Aug 21:1-19.
Topal IO1, Kocaturk Goncu OE, Gungor S, Durmuscan M, Sucu V, Yıldırmak S.

Vitamin D plays a key role in the immune responses generated by lymphocytes and antigen-presenting cells. Decreased vitamin 25-hydroxyvitamin D (25(OH)D) levels has been implicated in several allergic disorders and association between 25(OH)D levels and chronic urticaria (CU) symptom scores has been in a few studies. This study was performed to assess the effects of vitamin D supplementation on the symptoms and quality of life scores in chronic spontaneous urticaria and to vitamin D levels in CSU patients in comparison with controls.

Fifty-eight CSU patients and forty-five controls were included in the study. The patients were divided into two groups according to severity of the disease; as mild/moderate and severe urticaria. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were measured in serum of CSU patients and compared with the control groups. In patients with 25(OH)D concentrations lower than 30 µg/L, 300.000 IU/month of vitamin D3 supplementation was added to standard therapy. The clinical improvement was evaluated after 3 months with urticaria activity score (UAS4) and Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).

Serum 25(OH)D concentration was significantly lower in CSU group compared to healthy subjects (p<0.001). The prevalance of vitamin D deficiency (< 20 (µg/L) and insufficiency (< 30 µg/L) was significantly higher in CSU patients than control groups. In addition, 25(OH)D concentrations were significantly lower in both mild- moderate and severe CSU patients than those of the controls (P=0.011 and p<0.001, respectively). Ninety eight percent of patients (25(OH)D < 30 µg/L) were treated with vitamin D3 (300.000 IU/month-1) supplementation, and after 12 weeks, these patients showed significant improvements in UAS4 and CU-Q2oL scores.

This study support the contributing and beneficial effects of vitamin D in the treatment of chronic urticaria. Replacement of vitamin D may provide improvement in both the severity of symptoms and quality of life scores in these patients.

PMID: 26295454  Download the PDF from Vitamin D Life

CIU = chronic idiopathic urticaria

See also Vitamin D Life

See also web

  • Vitamin D Blog: Help for Hives? MedPageToday
    ‘’ In the first week, both groups saw a 33% decrease in symptoms. But only the high-dose vitamin D group saw a further reduction in symptoms (40%) by the end of the study.’’
    High dose = 4,000 IU vitamin D daily
  • UNMC study: Vitamin D provides relief for those with chronic hives Press Release
    “It was not a cure, but it showed benefit when added to anti-allergy medications. Patients taking the higher dose had less severe hives — they didn’t have as many hives and had a decrease in the number of days a week they had hives.
    In the study, patients had suffered from five to 20 years with severe hives. Some had been on therapy and others none.
  • Prevalence of Sensitivity to Food and Drug Additives in Patients With Chronic Idiopathic Urticaria March 2014
    Double blind placebo controlled challenges found that Chronic Hives was NOT associated with drug sensitivities. No mention of Vitamin D
    FD&C Yellow 5, potassium metabisulfite, monosodium glutamate, aspartame, sodium benzoate, methyl paraben, butylated hydroxy anisole, butylated hydroxy toluene, FD&C Yellow 6, sodium nitrate, sodium nitrite.
  • Does a low vitamin d level cause hives? Answers.com Aug 2014?
    One person's experience. Vitamin D levels dropped, got hives, which were went away when his vitamin D levels were raised

Title revision of Jan 2020 caused the visitor count to reset.
There have actually been 146026 visitors to this page since it was originally made

Created by admin. Last Modification: Sunday September 6, 2020 09:41:55 GMT-0000 by admin. (Version 24)

Attached files

ID Name Comment Uploaded Size Downloads
14273 Hives sci-hub.pdf PDF 2020 admin 06 Sep, 2020 09:33 203.61 Kb 79
6637 Topal IO 2016.pdf PDF admin 04 May, 2016 18:02 408.14 Kb 1463
5197 Hives Iran.jpg admin 19 Mar, 2015 17:07 12.80 Kb 5888
5196 Hives Iran.pdf admin 19 Mar, 2015 17:07 224.72 Kb 2406
See any problem with this page? Report it (FINALLY WORKS)